Ipsen: 2014 Half-Year Results And 2014 Objectives

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PARIS--(BUSINESS WIRE)--Regualtory News: The Board of Directors of Ipsen (Euronext: IPN; ADR: IPSEY), chaired by Marc de Garidel, met on 28 August 2014 to approve the financial statements for the first half 2014, published today. The interim financial report, with regard to regulated information, is available on the Group’s website, www.ipsen.com, under the Regulated Information tab in the Investor Relations section. The 2014 half year financial statements are subject to a limited review by statutory auditors.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC